Stay updated on Nivolumab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now references revision v3.5.4 instead of v3.5.3, signaling a backend/UI update without changes to the trial details or core content.
    Difference
    0.0%
    Check dated 2026-05-16T00:00:25.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page’s footer shows an updated site/system software revision from v3.5.2 to v3.5.3, without altering the underlying study details.
    Difference
    0.0%
    Check dated 2026-04-24T17:10:48.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T13:42:53.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T22:34:39.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This appears to be a minor metadata update with no impact on study content or functionality.
    Difference
    0.0%
    Check dated 2026-03-11T17:56:19.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Deleted: the government funding lapse notice and the earlier Revision: v3.4.1; these are administrative changes and do not affect the study content, eligibility criteria, or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T03:08:44.000Z thumbnail image

Stay in the know with updates to Nivolumab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Hodgkin Lymphoma Clinical Trial page.